[Federal Register Volume 84, Number 248 (Friday, December 27, 2019)]
[Notices]
[Page 71465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27951]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-571]


Bulk Manufacturer of Controlled Substances Application: Johnson 
Matthey Pharmaceutical Materials Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before February 25, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: 
    In accordance with 21 CFR 1301.33(a), this is notice that on 
October 31, 2019, Johnson Matthey Pharmaceutical Materials Inc., 25 
Patton Road, Devens, Massachusetts 01434 applied to be registered as a 
bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Amphetamine...........................       1100  II
Methylphenidate.......................       1724  II
Nabilone..............................       7379  II
Hydrocodone...........................       9193  II
Levorphanol...........................       9220  II
Alfentanil............................       9737  II
Remifentanil..........................       9739  II
Sufentanil............................       9740  II
------------------------------------------------------------------------

    The company plans to utilize this facility to manufacture small 
quantities of the listed controlled substances in bulk for distribution 
to its customers as well as to conduct analytical testing in support of 
the company's primary manufacturing facility in West Deptford, New 
Jersey.

    Dated: December 17, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-27951 Filed 12-26-19; 8:45 am]
 BILLING CODE 4410-09-P